Australian Clinical Labs (ASX:ACL) Days Sales Outstanding

: 33.90 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

Australian Clinical Labs's average Accounts Receivable for the six months ended in Dec. 2023 was A$62.7 Mil. Australian Clinical Labs's Revenue for the six months ended in Dec. 2023 was A$337.8 Mil. Hence, Australian Clinical Labs's Days Sales Outstanding for the six months ended in Dec. 2023 was 33.90.

The historical rank and industry rank for Australian Clinical Labs's Days Sales Outstanding or its related term are showing as below:

ASX:ACL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.11 Med: 27.84 Max: 37.85
Current: 37.85

During the past 4 years, Australian Clinical Labs's highest Days Sales Outstanding was 37.85. The lowest was 20.11. And the median was 27.84.

ASX:ACL's Days Sales Outstanding is ranked better than
85.78% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs ASX:ACL: 37.85

Australian Clinical Labs's Days Sales Outstanding declined from Dec. 2022 (36.30) to Dec. 2023 (33.90).

Australian Clinical Labs Days Sales Outstanding Historical Data

The historical data trend for Australian Clinical Labs's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Days Sales Outstanding

27.84

20.11

30.65

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding		30.17	40.16	36.30	37.07	33.90

Competitive Comparison

For the Diagnostics & Research subindustry, Australian Clinical Labs's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs Days Sales Outstanding Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Days Sales Outstanding falls into.

Australian Clinical Labs Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Australian Clinical Labs's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (64.888	+	51.352)	/	2 )	/	692.103	*	365
=	58.12					/	692.103	*	365
=	30.65

Australian Clinical Labs's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (51.352	+	74.138)	/	2 )	/	337.816	*	365 / 2
=	62.745					/	337.816	*	365 / 2
=	33.90

Australian Clinical Labs (ASX:ACL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Australian Clinical Labs Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines